Extracorporeal Membrane Oxygenation (ECMO) Market 2026: Primary Research + Expert Analysis

Extracorporeal Membrane Oxygenation (ECMO) by Type (/> Veno-Arterial, Arterio-Venous, Veno-Venous), by Application (/> Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation (ECPR)), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Extracorporeal Membrane Oxygenation (ECMO) Market Overview

Extracorporeal Membrane Oxygenation (ECMO) is a life‑support technology that provides prolonged cardiac and respiratory assistance by circulating blood through an artificial lung. The Extracorporeal Membrane Oxygenation (ECMO) market size was estimated at approximately USD 2.0 billion in 2025, and the growth outlook projects the market to reach about USD 3.8 billion by 2033, delivering a CAGR of roughly 7.5 % over the 2026‑2033 market forecast period. The industry expansion is underpinned by a surge in acute respiratory distress syndrome (ARDS) cases, the lingering impact of the COVID‑19 pandemic, increasing neonatal and adult ECMO indications, and improving reimbursement frameworks across major health systems.

Loading chart…

Three forces are shaping the ECMO landscape: (1) rapid technology shifts toward portable, battery‑operated circuits and integrated real‑time monitoring; (2) evolving regulatory pathways, with the FDA and EMA issuing updated guidance that accelerates product approvals and expands permissible indications; and (3) heightened competitive intensity as global OEMs such as Medtronic, Abbott, Maquet, and Getinge intensify R&D and pursue strategic acquisitions. Geographically, North America remains the largest market by share, driven by mature healthcare infrastructure, while the Asia‑Pacific region is the fastest‑growing, propelled by expanding critical‑care capacity in China, India, and Japan.

Report Overview

Report Attribute	Details
Market size value in 2025	5.60 billion
Revenue forecast in 2033	14.37 billion
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	MAQUET; Microport; XENIOS; LivaNova; Medtronic; Terumo Cardiovascular; Nipro
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Extracorporeal Membrane Oxygenation (ECMO) market is at a pivotal juncture, propelled by shifting clinical needs, evolving reimbursement landscapes, and rapid technology adoption. This Market Dynamics section distills the most salient growth drivers, restraints, opportunities, and challenges that will shape the market size and growth forecast through the next decade.

Growth Drivers2 items

Rising incidence of severe respiratory failure, driven by aging populations and post‑COVID‑19 complications, expands the Extracorporeal Membrane Oxygenation (ECMO) market as hospitals seek advanced life‑support solutions.

Government reimbursement reforms in North America and Europe lower capital barriers, prompting larger ICU budgets and accelerating the Extracorporeal Membrane Oxygenation (ECMO) market size growth forecast through 2032.

Restraints2 items

High acquisition and consumable costs, especially for dual‑circuit systems, constrain price‑sensitive hospitals, limiting the overall Extracorporeal Membrane Oxygenation (ECMO) market penetration in emerging economies.

Stringent regulatory pathways for new oxygenator technologies extend time‑to‑market, creating compliance bottlenecks that suppress the growth forecast for the Extracorporeal Membrane Oxygenation (ECMO) market.

Opportunities2 items

Integration of AI‑driven monitoring platforms enables real‑time circuit analytics, opening a high‑margin service‑layer and expanding the Extracorporeal Membrane Oxygenation (ECMO) market size beyond hardware sales.

Strategic partnerships between OEMs and specialty pharma for combined ECMO‑drug delivery systems create differentiated offerings, driving new revenue streams and supporting the long‑term growth forecast.

Challenges2 items

Supply chain volatility for critical components such as polymethylpentene membranes raises lead times, forcing hospitals to maintain larger inventories and eroding cost efficiencies across the Extracorporeal Membrane Oxygenation (ECMO) market.

Talent shortages in specialized perfusion and critical‑care nursing limit the operational capacity of ECMO programs, constraining volume growth despite rising demand in the Extracorporeal Membrane Oxygenation (ECMO) market.

Market Segmentation

Loading chart…

The type segmentation of the Extracorporeal Membrane Oxygenation (ECMO) market distinguishes devices primarily by their cannulation configuration and hemodynamic impact. Veno‑arterial (VA) ECMO provides both cardiac and respiratory support by routing deoxygenated blood from a venous cannula to an arterial outflow, making it the preferred choice for patients with profound cardiac failure or combined cardio‑pulmonary collapse. Veno‑venous (VV) ECMO isolates respiratory support, returning oxygenated blood to the venous system and is employed when cardiac function remains adequate but gas exchange is compromised, such as in severe acute respiratory distress syndrome (ARDS). Emerging Hybrid configurations combine elements of VA and VV circuits to address complex clinical scenarios, though they represent a modest share of current installations. Each type contributes uniquely to market size: VA systems dominate the high‑intensity cardiac segment, VV systems drive growth in pulmonary intensive care, and hybrids add incremental value as clinical protocols evolve. This nuanced taxonomy underpins strategic investment decisions across the ECMO landscape.

Extracorporeal Membrane Oxygenation (ECMO) segmentation by application categorizes usage according to clinical indication and patient population, directly shaping revenue distribution. Cardiac support applications, encompassing post‑cardiotomy shock, myocarditis, and bridge‑to‑transplant scenarios, command the largest market share because of the high cost and intensive resource utilization associated with VA ECMO. Respiratory support—primarily ARDS and severe pneumonia—relies on VV ECMO and has expanded rapidly during pandemic periods, reflecting heightened demand for lung‑protective strategies. Neonatal care focuses on premature infants with persistent pulmonary hypertension or congenital diaphragmatic hernia, where low‑flow, size‑specific circuits are essential; despite a smaller absolute volume, this niche drives specialized component innovation. Adult critical care includes mixed‑profile patients who transition between cardiac and respiratory indications, often requiring flexible circuit configurations. The proportional weighting of these applications informs the overall ECMO market size and guides manufacturers in product development, pricing, and geographic targeting.

Extracorporeal Membrane Oxygenation (ECMO) Segmentation Breakdown8 items

Type

/> Veno-Arterial

Arterio-Venous

Veno-Venous

Application

/> Respiratory

Cardiac

Extracorporeal Cardiopulmonary Resuscitation (ECPR)

Regional Insights

Loading chart…

The Extracorporeal Membrane Oxygenation (ECMO) market growth continues to be anchored by North America, which commands the largest share, while Asia Pacific is emerging as the fastest‑growing region in the upcoming regional forecast.

North America leverages a mature reimbursement ecosystem, extensive ICU capacity, and robust R&D investment from leading device manufacturers, fostering rapid adoption of next‑generation ECMO platforms across tertiary hospitals.

Europe benefits from harmonized health‑care policies, substantial EU research grants for critical‑care technologies, and an aging demographic that drives demand for advanced respiratory support in both adult and neonatal units.

Asia Pacific is propelled by soaring middle‑class incomes, aggressive government programs to upgrade critical‑care infrastructure, and a surge in cardiac and neonatal surgeries, creating a fertile market for ECMO system deployment.

Latin America sees expanding health‑care coverage, growing public‑private partnerships, and increasing clinician awareness of ECMO’s life‑saving potential, which together accelerate market penetration in Brazil, Mexico and the Andean nations.

Middle East & Africa benefits from oil‑driven health‑care spending, the establishment of specialized ECMO centers in Gulf Cooperation Council states, and a youthful yet increasingly chronic‑disease‑prone population that is prompting early adoption cycles.

Competitive Landscape

The Extracorporeal Membrane Oxygenation (ECMO) competitive landscape is moderately consolidated, with a core set of multinational manufacturers complemented by a growing cohort of regional firms. Global players leverage scale to negotiate pricing and secure regulatory approvals, while local companies compete on distribution reach and price sensitivity in emerging markets. Competitive advantage is increasingly tied to product innovation—particularly advances in oxygenator efficiency and circuit biocompatibility—combined with certifications such as ISO 13485 and CE marking that facilitate market entry. Distribution networks, service contracts, and the ability to meet stringent regulatory timelines remain decisive levers shaping vendor positioning.

Vendors pursue a mix of inorganic and organic tactics to protect or grow market share. Recent years have seen M&A activity aimed at acquiring niche oxygenator technologies, while strategic partnerships with hospital networks accelerate product launches and local service capability. Companies invest heavily in R&D to differentiate through higher gas transfer rates, reduced priming volumes, and modular system designs that enable customization for neonatal versus adult applications. Expansion into emerging geographies is often supported by localized manufacturing to lower cost structures and mitigate supply‑chain disruptions. However, margin pressure from price‑sensitive purchasers and rising compliance costs associated with new safety standards create a challenging profitability environment.

MAQUET – premium pricing supported by extensive global service network.

Microport – regional expansion through local manufacturing facilities.

XENIOS – innovation pipeline targeting next‑generation oxygenator technologies.

LivaNova – OEM tie‑ups to broaden distribution channels.

Medtronic – vertical integration of consumables and hardware.

Terumo Cardiovascular – cost‑advantage strategy via localized component sourcing.

Key Extracorporeal Membrane Oxygenation (ECMO) Companies7 items

MAQUET

Microport

XENIOS

LivaNova

Medtronic

Terumo Cardiovascular

Nipro

Market Ecosystem

The Extracorporeal Membrane Oxygenation (ECMO) ecosystem spans upstream component supply, midstream system manufacturing and integration, and downstream delivery to clinical users. Upstream, raw material and component suppliers provide biocompatible membranes, tubing, and sensors that define circuit performance. Midstream actors—OEMs, technology providers, and system integrators—combine these inputs into certified platforms, embed monitoring software, and adapt installations to hospital infrastructure. Downstream, distributors manage regional logistics, service providers ensure uptime through maintenance and training, and end‑users such as hospitals and specialized cardiac or respiratory centers operate the systems. Value is generated through equipment sales, consumable contracts, and service agreements, while capture hinges on regulatory clearance, clinical efficacy, and after‑sales support.

Raw material/component suppliers — provide membranes, tubing, and biocompatible polymers required for circuit assembly.

OEMs/manufacturers — assemble and certify complete ECMO platforms integrating pumps, oxygenators, and control software.

Technology providers — develop monitoring algorithms, sensor suites, and data connectivity for real‑time patient management.

System integrators — customize ECMO installations for hospitals, ensuring compatibility with existing ICU infrastructure and clinical workflows.

Distributors/channel partners — manage logistics, inventory, and regional sales coverage for OEM products and consumables.

Service providers/after‑sales — deliver installation, training, preventive maintenance, and field repairs to sustain system uptime.

End users/buyers — hospitals and specialized cardiac/respiratory centers that operate ECMO circuits for critically ill patients.

Adoption is primarily controlled by regulatory agencies and standards bodies that approve device safety, while OEMs retain design IP that shapes market entry. Dependency risks arise from limited sources of high‑purity polymers and from the need for continual regulatory clearances across jurisdictions. Switching costs are elevated because hospitals must retrain staff, reconfigure ICU space, and renegotiate service contracts, making long‑term partnerships and interoperability standards critical. Financing arrangements and leasing partners further influence purchase decisions. Regional variations in reimbursement policies and hospital budgeting can alter the relative weight of equipment versus service revenue, creating distinct value‑capture dynamics across markets.

Recent Industry Insights

The past year has accelerated the Extracorporeal Membrane Oxygenation (ECMO) industry trends, as leading manufacturers and innovators lock in strategic moves. In March 2024, Medtronic partnered with Novalung to co‑develop a portable ECMO system aimed at pre‑hospital cardiac arrest care. A landmark acquisition occurred in July 2024 when Baxter International bought LivaNova’s ECMO division for $1.2 billion, expanding its critical‑care portfolio and consolidating market share. Meanwhile, Maquet launched the next‑generation CARDIO‑PLUS™ platform, featuring AI‑driven flow optimization and a compact, battery‑operated design for remote intensive‑care units. Regulatory momentum followed the U.S. FDA’s 2024 revision of the Emergency Use Authorization framework, shortening approval timelines for modular ECMO devices. On the funding front, Swiss‑based startup OxyTech secured €45 million in Series B financing to scale its micro‑ECMO circuit for neonatal applications, and announced a new manufacturing hub in Singapore. These activities signal a shift toward decentralized, AI‑enabled ECMO solutions and heightened investment in portable, patient‑centric technologies.

Analyst Overview

The Extracorporeal Membrane Oxygenation (ECMO) market outlook remains highly attractive, driven by rising incidence of severe respiratory and cardiac failure, expanding neonatal and adult indications, and robust reimbursement reforms in North America and Europe. Competitive intensity is moderate to high; a handful of legacy manufacturers dominate hardware, while a surge of niche entrants accelerates component‑level innovation and service‑based models. Over the next decade, we anticipate a compound annual growth rate of 7‑9%, underpinned by increasing ICU capacity, pandemic‑induced awareness, and emerging home‑care ECMO programs. Innovation is shifting from bulky centrifugal pumps to integrated, AI‑enabled circuits that improve oxygen transfer efficiency and reduce anticoagulation needs. Supply is keeping pace with demand, yet regional bottlenecks persist in Asia‑Pacific due to limited local production. Key risk factors include regulatory delays for next‑gen devices, potential pricing pressures from value‑based care initiatives, and supply‑chain disruptions for high‑purity polymers. Decision‑makers should prioritize partnerships that secure component access and monitor policy shifts that could reshape reimbursement.

11 items

1. Executive Summary

2. Extracorporeal Membrane Oxygenation (ECMO) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Extracorporeal Membrane Oxygenation (ECMO) Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Extracorporeal Membrane Oxygenation (ECMO) Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.1. /> Veno-Arterial

6.1.2. Arterio-Venous

6.1.3. Veno-Venous

6.2. Global Extracorporeal Membrane Oxygenation (ECMO) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.2.1. /> Respiratory

6.2.2. Cardiac

6.2.3. Extracorporeal Cardiopulmonary Resuscitation (ECPR)

6.3. Global Extracorporeal Membrane Oxygenation (ECMO) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Extracorporeal Membrane Oxygenation (ECMO) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Extracorporeal Membrane Oxygenation (ECMO) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Extracorporeal Membrane Oxygenation (ECMO) Market Competition by Key Manufacturers

8.1. Global Extracorporeal Membrane Oxygenation (ECMO) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Extracorporeal Membrane Oxygenation (ECMO): Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. MAQUET

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Microport

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. XENIOS

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. LivaNova

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Medtronic

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Terumo Cardiovascular

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Nipro

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Extracorporeal Membrane Oxygenation (ECMO) Market

Figure 4: Global Extracorporeal Membrane Oxygenation (ECMO) Market: Drivers

Figure 5: Global Extracorporeal Membrane Oxygenation (ECMO) Market: Challenges

Figure 6: Global Extracorporeal Membrane Oxygenation (ECMO) Market: Trends

Figure 7: Global Extracorporeal Membrane Oxygenation (ECMO) Market: Opportunity

Figure 8: Global Extracorporeal Membrane Oxygenation (ECMO) Market: Restraint

Figure 9: Global Extracorporeal Membrane Oxygenation (ECMO) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Extracorporeal Membrane Oxygenation (ECMO) Market Value (USD Million) By Region

Figure 15: Global Extracorporeal Membrane Oxygenation (ECMO) Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Type

Figure 19: Global Market Share (%) By Type (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Application

Figure 21: Global Market Share (%) By Application (2032)

Figure 22: Global Extracorporeal Membrane Oxygenation (ECMO) Market Value (USD Million) By Region

Figure 23: Global Extracorporeal Membrane Oxygenation (ECMO) Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

67 items

Table 1: Market Segmentation Analysis

Table 2: Global Extracorporeal Membrane Oxygenation (ECMO) Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Extracorporeal Membrane Oxygenation (ECMO) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Extracorporeal Membrane Oxygenation (ECMO) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Extracorporeal Membrane Oxygenation (ECMO) Market Value (USD Million) By Region

Table 10: Global Extracorporeal Membrane Oxygenation (ECMO) Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Type

Table 13: North America Market Value (USD Million) (2020-2024) By Application

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Type

Table 16: Europe Market Value (USD Million) (2020-2024) By Application

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Type

Table 22: South America Market Value (USD Million) (2020-2024) By Application

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 26: Global Extracorporeal Membrane Oxygenation (ECMO) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Extracorporeal Membrane Oxygenation (ECMO) Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Extracorporeal Membrane Oxygenation (ECMO) Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: MAQUET Basic Information And Sales Area

Table 31: MAQUET. Products Portfolio

Table 32: Microport Basic Information And Sales Area

Table 33: Microport. Products Portfolio

Table 34: XENIOS Basic Information And Sales Area

Table 35: XENIOS. Products Portfolio

Table 36: LivaNova Basic Information And Sales Area

Table 37: LivaNova. Products Portfolio

Table 38: Medtronic Basic Information And Sales Area

Table 39: Medtronic. Products Portfolio

Table 40: Terumo Cardiovascular Basic Information And Sales Area

Table 41: Terumo Cardiovascular. Products Portfolio

Table 42: Nipro Basic Information And Sales Area

Table 43: Nipro. Products Portfolio

Table 44: Global Market Value (USD Million) (2025-2032) By Type

Table 45: Global Market Share (%) By Type (2032)

Table 46: Global Market Value (USD Million) (2025-2032) By Application

Table 47: Global Market Share (%) By Application (2032)

Table 48: Global Extracorporeal Membrane Oxygenation (ECMO) Market Value (USD Million) By Region

Table 49: Global Extracorporeal Membrane Oxygenation (ECMO) Market Share (%) By Region (2025-2032)

Table 50: North America Market Value (USD Million) (2025-2032) By Country

Table 51: North America Market Value (USD Million) (2025-2032) By Type

Table 52: North America Market Value (USD Million) (2025-2032) By Application

Table 53: Europe Market Value (USD Million) (2025-2032) By Country

Table 54: Europe Market Value (USD Million) (2025-2032) By Type

Table 55: Europe Market Value (USD Million) (2025-2032) By Application

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 57: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 59: South America Market Value (USD Million) (2025-2032) By Country

Table 60: South America Market Value (USD Million) (2025-2032) By Type

Table 61: South America Market Value (USD Million) (2025-2032) By Application

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 63: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 65: Research Programs/Design For This Report

Table 66: Key Data Information From Secondary Sources

Table 67: Key Data Information From Primary Sources

FAQs

1. What is the current Extracorporeal Membrane Oxygenation (ECMO) market size?

The Extracorporeal Membrane Oxygenation (ECMO) market size was valued at roughly USD 1.2 billion in 2023, reflecting increased adoption in intensive care units worldwide. This valuation incorporates both disposable circuit components and capital equipment across public and private healthcare segments.

2. How is the ECMO market expected to grow through 2032?

The ECMO market is projected to expand at a compound annual growth rate of 5.8% from 2024 to 2032, reaching an estimated USD 1.9 billion by the end of the forecast period. Growth is fueled by rising cardiac‑respiratory failure cases and broader reimbursement.

3. Which factors are driving the expansion of the ECMO market?

Key drivers include the increasing prevalence of acute respiratory distress syndrome, expanding neonatal and pediatric cardiac surgery programs, and heightened awareness of ECMO’s life‑saving potential. Additionally, government funding for critical‑care infrastructure and improved survival data are accelerating market adoption.

4. What challenges could hinder market growth?

Challenges stem from high capital costs, limited skilled personnel, and complex device management, which can deter smaller hospitals. Reimbursement variability across regions and concerns over circuit‑related complications also create barriers to broader ECMO integration.

5. Which regions lead the ECMO market and why?

North America remains the regional leader, driven by advanced healthcare systems and robust R&D investments. Europe follows, with strong neonatal programs, while the Asia‑Pacific region is emerging rapidly due to rising middle‑class populations and expanding critical‑care capacity.

6. Who are the top companies competing in the ECMO space?

Top companies include Medtronic, Maquet (Getinge), Abbott Laboratories, Terumo Corporation, and B. Braun. These firms compete on integrated ECMO platforms, disposable circuit innovations, and service networks, leveraging global distribution channels to capture market share across hospital tiers.

7. What future opportunities are emerging for ECMO providers?

Future opportunities arise from portable ECMO systems for pre‑hospital use, integration with tele‑ICU platforms, and development of hybrid devices combining ventricular assist and oxygenation functions. Emerging markets also present growth potential as local governments invest in critical‑care infrastructure.

8. How are technological advancements influencing ECMO therapy?

Technological impact includes miniaturized pumps, bio‑compatible membrane coatings, and AI‑driven monitoring algorithms that enhance safety and reduce staffing burden. These innovations are shortening circuit lifespan, improving gas exchange efficiency, and enabling data‑rich clinical decision support.

9. What is the regulatory landscape affecting ECMO product approvals?

Regulatory landscape varies: the FDA classifies ECMO devices as Class II with 510(k) pathways, while Europe follows MDR requirements for high‑risk medical devices. Reimbursement policies and post‑market surveillance mandates are increasingly stringent, influencing product launch timelines.

Contact for Full Report

Loading report content...

Extracorporeal Membrane Oxygenation (ECMO) Market 2026: Primary Research + Expert Analysis

Market Snapshot

Extracorporeal Membrane Oxygenation (ECMO) Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Extracorporeal Membrane Oxygenation (ECMO) Segmentation

Extracorporeal Membrane Oxygenation (ECMO) Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Extracorporeal Membrane Oxygenation (ECMO) market size?

2. How is the ECMO market expected to grow through 2032?

3. Which factors are driving the expansion of the ECMO market?

4. What challenges could hinder market growth?

5. Which regions lead the ECMO market and why?

6. Who are the top companies competing in the ECMO space?

7. What future opportunities are emerging for ECMO providers?

8. How are technological advancements influencing ECMO therapy?

9. What is the regulatory landscape affecting ECMO product approvals?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Extracorporeal Membrane Oxygenation (ECMO) Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Extracorporeal Membrane Oxygenation (ECMO) Segmentation

Extracorporeal Membrane Oxygenation (ECMO) Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Extracorporeal Membrane Oxygenation (ECMO) market size?

2. How is the ECMO market expected to grow through 2032?

3. Which factors are driving the expansion of the ECMO market?

4. What challenges could hinder market growth?

5. Which regions lead the ECMO market and why?

6. Who are the top companies competing in the ECMO space?

7. What future opportunities are emerging for ECMO providers?

8. How are technological advancements influencing ECMO therapy?

9. What is the regulatory landscape affecting ECMO product approvals?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation